ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 084

Rheum to Improve: Patient-reported Transition Readiness in a Large Pediatric Rheumatology Clinic

Kristiana Nasto1, David McDonald1, Kyla Fergason1, Mary Robichaux1, Bernard Danna1, Monique Maher1, Alexander Alexander1, Danielle Guffey1, Miriah Gillispie-Taylor2 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Health policy, Pediatric rheumatology, practice guidelines, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Quality, Health Services, and Education I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: Transition of adolescents with chronic healthcare needs to adult care may result in poor outcomes. We have developed a program to improve the transition of pediatric rheumatology patients to adult rheumatology providers, which includes periodic assessment of patient self-reported transition readiness using the validated Adolescent Assessment of Preparation for Transition (ADAPT) survey. Our long-term goal is to identify factors that can predict successful transition; here, we report initial findings following electronic medical record (EMR) automation of ADAPT delivery.

Methods: Return patients 14 years and older were surveyed, irrespective of diagnosis, from July 2021-November 2022. ADAPT survey distribution was automated for all clinic visits using the EMR. Patients/caregivers could respond during electronic clinic check-in, which is available for both in-person and telehealth visits. ADAPT responses were automatically collated using EMR data extraction on the first of each month. Three composite scores, out of 100, for (1) self-management, (2) prescription management, and (3) transfer planning were manually calculated from the ADAPT responses and compared across demographics. Mann-Whitney, Wilcoxon and Kruskal-Wallis tests were used to compare composite scores.

Results: 462 unique patients returned 670 surveys. 87% of returned surveys (586/670) were scorable for at least 1 composite score, and 401 patients (87%) returned a survey with at least 1 calculatable composite score. Most survey respondents were female (75%), aged 14-17 years (83%), Caucasian (69%), non-Hispanic (64%), and spoke English (90%). Overall mean scores for self-management, prescription management, and transfer planning on initial survey were 35 (n=401), 59 (n=288), and 16.6 (n=367), respectively. Scores for self-management (mean 20.4 at age 14 years, increasing to 63.6 at 18+ years) and transfer planning (mean 1 at age 14 years, increasing to 49 at 18+ years) improved across age (both p 0.0001), but scores for prescription management were high for all patients (mean 59 at age 14, 66 at 18+ years, p=0.0442). Scores did not differ by sex or race; Hispanic patients scored higher in self-management (44.5 vs. 30.7, p 0.0001). 97 patients (21%) completed 2 surveys, 39 patients (8.4%) completed 3 or more. The average time between surveys 1 and 2 was 4 months (range 1 day-16 months). There was no difference in this timeframe in self-management (33 vs. 35.3, p=0.444, n=87) or prescription management (60 vs. 58.6, p=0.908, n=54), but there was an increase in scores for transfer planning (13.6 vs. 21, p=0.008, n=90).

Conclusion: In our rheumatology transition program, patient self-reported transition readiness is assessed using the ADAPT survey. Analysis thus far indicates participation in the transition pathway can rapidly improve transfer planning scores; however, opportunities remain to improve readiness in all domains. We look forward to distributing surveys in Spanish, a current EMR limitation. In the future, we will assess which aspects of readiness correlate with successful transfer to adult care.


Disclosures: K. Nasto: None; D. McDonald: None; K. Fergason: None; M. Robichaux: None; B. Danna: None; M. Maher: None; A. Alexander: None; D. Guffey: None; M. Gillispie-Taylor: Pfizer, 5; T. Vogel: Moderna, 2, Novartis, 2, Pfizer, 2, sobi, 2.

To cite this abstract in AMA style:

Nasto K, McDonald D, Fergason K, Robichaux M, Danna B, Maher M, Alexander A, Guffey D, Gillispie-Taylor M, Vogel T. Rheum to Improve: Patient-reported Transition Readiness in a Large Pediatric Rheumatology Clinic [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/rheum-to-improve-patient-reported-transition-readiness-in-a-large-pediatric-rheumatology-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheum-to-improve-patient-reported-transition-readiness-in-a-large-pediatric-rheumatology-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology